- 11012台北市信義區基隆路一段333號18樓1806室
- Taiwania Capital Management USA, Inc 3945 Freedom Circle, Suite 760, Santa Clara, CA 95054
Portfolio
Updated：
Ambiq Micro (Fund I)
Ultra-low power MCUs for weables and IoT devices
AnnJI Pharma (Fund II)
Small molecule drugs for dermatology and neurology
AEye (Fund I)
Delivering human perception for autonomous vehicles
Arris Composites (Fund I)
Revolutionizing the manufacturing process of carbon fiber composites
C4 Therapeutics (Fund II)
Destroying proteins that cause cancers, neurological, and other diseases
DSP Concepts (Fund I)
The ultimate solution provider for audio DSP
EirGenix (Fund II)
Making biosimilars affordable and accessible to patients everywhere
ELIXIRON (Fund II)
Unique Immunotherapies for presently untreatable cancers and chronic hepatitis B
FRACTYL (Fund II)
Leveraging intestinal biology to transform the treatment of metabolic diseases
Frequency Therapeutics (Fund II)
Activating the body’s innate healing ability to treat degenerative diseases
Handa Pharma (Fund II)
Niche new drugs and high barrier/patentable products
LANDING AI (Fund I)
Helping companies jumpstart AI adoption and create real business value today
LIGHT FIELD LAB (Fund I)
Real holograms without the need of headgears
MedicusTeck (Fund I)
Predictive bed fall prevention and patient monitoring tool
Mechavision (Fund I)
Empowering human-machine collaboration through touch
Metanoia Communications Inc. (Fund I)
System on Chip (SoC) solutions for fixed line communication
OCULii (Fund I)
Breakthrough 4D radar imaging for autonomous systems
Pavilion Data Systems (Fund I)
High performance storage solution for enterprises
PharmaEssentia (Fund II)
Novel treatments for myeloproliferative neoplasms (MPNs), hepatitis, and cancers
Point Robotics MedTec (Fund II)
Advanced robotics that makes spinal surgeries safer than ever
Regenacy Pharmaceuticals (Fund II)
Restoring nerve function to treat diabetic and other peripheral neuropathies
TRICORNTECH (Fund I)
Laboratory-grade VoC detectors for real time monitoring
Viracta (Fund II)
New medicines for cancers and virus-associated diseases
XGene (Fund II)
Small molecule drugs for acute pain, chronic pain and infectious diseases